ArticleJournal of experimental & clinical cancer research : CR2023
Correction: Synthetic tetracycline-controllable shRNA targeting long non-coding RNA HOXD-AS1 inhibits the progression of bladder cancer.
Jianfa Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.